VANGUARD GROUP INC

Holdings History for NEPHROS INC - Common Stock - $0.001 par value (NEPH)

Symbol: NEPH on Nasdaq
Investment type: Equity / Common Stock - $0.001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$1,140,183	233,644	-47,662	-17%	$4.88	Q4 2025
30 Sep 2025	0%	-0%	$1,330,578	281,306	-42,137	-13%	$4.73	Q3 2025
30 Jun 2025	0%	+0%	$1,322,882	323,443	+119,285	+58%	$4.09	Q2 2025
31 Mar 2025	0%	0%	$351,152	204,158	+2,164		$1.72	Q1 2025
31 Dec 2024	0%	0%	$294,911	201,994	0		$1.46	Q4 2024
30 Sep 2024	0%	0%	$345,410	201,994	+7,970	+4.1%	$1.71	Q3 2024
30 Jun 2024	0%	+0%	$409,391	194,024	+18,375	+10%	$2.11	Q2 2024
31 Mar 2024	0%	0%	$384,671	175,649	+4,339	+2.5%	$2.19	Q1 2024
31 Dec 2023	0%	0%	$592,733	171,310	+598	+0.35%	$3.46	Q4 2023
30 Sep 2023	0%	0%	$252,654	170,712	+6,414	+3.9%	$1.48	Q3 2023
30 Jun 2023	0%	+0%	$254,662	164,298	+17,613	+12%	$1.55	Q2 2023
31 Mar 2023	0%	0%	$156,938	146,685	0		$1.07	Q1 2023
31 Dec 2022	0%	0%	$169,744	146,685	-1,098	-0.74%	$1.16	Q4 2022
30 Sep 2022	0%	+0%	$134,000	147,783	+25,105	+20%	$0.91	Q3 2022
30 Jun 2022	0%	0%	$188,000	122,678	-300	-0.24%	$1.53	Q2 2022
31 Mar 2022	0%	0%	$541,000	122,978	0		$4.40	Q1 2022
31 Dec 2021	0%	+0%	$726,000	122,978	+21,360	+21%	$5.90	Q4 2021
30 Sep 2021	0%	0%	$891,000	101,618	+1,682	+1.7%	$8.77	Q3 2021
30 Jun 2021	0%	+0%	$1,014,000	99,936	+3,741	+3.9%	$10.15	Q2 2021
31 Mar 2021	0%	+0%	$640,000	96,195	+28,756	+43%	$6.65	Q1 2021
31 Dec 2020	0%	+0%	$578,000	67,439	+10,702	+19%	$8.57	Q4 2020
30 Sep 2020	0%	0%	$410,000	56,737	0		$7.23	Q3 2020
30 Jun 2020	0%	0%	$476,000	56,737	0		$8.39	Q2 2020
31 Mar 2020	0%	+0%	$357,000	56,737	+56,737	NEW	$6.29	Q1 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.